Evaluation of efficacy and safety of postoperative proton beam therapy for resectable pancreatic cancer

A prospective interventional study to evaluate the efficacy and safety of radical resection and postoperative proton beam therapy for resectable borderline or unresectable locally advanced pancreatic cancer - Evaluation of efficacy and safety of postoperative proton beam therapy for resectable pancreatic cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000051399

Enrollment

Registered

2023-07-01

Start date

2023-06-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Borderline resectable or unresectable locally advanced pancreatic cancer

Interventions

Proton therapy after radical surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. borderline or unresectable pancreatic cancer 2. pathologically diagnosed 3. patient's informed consent

Exclusion criteria

Exclusion criteria: 1. history of radiation therapy to the abdomen

Design outcomes

Primary

Measure	Time frame
efficacy and safety	—

Countries

Japan

Contacts

Public ContactKazuki Terashima

Hyogo Ion Beam Medical Center Department of Radiology

terashima@kmyr.jp0791-58-0100

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026